Small Molecule Therapeutics
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer
Leslie A. Parsels, Carl G. Engelke, Joshua Parsels, Sheryl A. Flanagan, Qiang Zhang, Daria Tanska, Daniel R. Wahl, Christine E. Canman, Theodore S. Lawrence and Meredith A. Morgan
Leslie A. Parsels
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Carl G. Engelke
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Joshua Parsels
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Sheryl A. Flanagan
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Qiang Zhang
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Daria Tanska
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Daniel R. Wahl
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Christine E. Canman
2Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan.
Theodore S. Lawrence
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Meredith A. Morgan
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
DOI: 10.1158/1535-7163.MCT-20-0365 Published February 2021

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
February 2021
Volume 20, Issue 2
Volume 20, Issue 2
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer
Leslie A. Parsels, Carl G. Engelke, Joshua Parsels, Sheryl A. Flanagan, Qiang Zhang, Daria Tanska, Daniel R. Wahl, Christine E. Canman, Theodore S. Lawrence and Meredith A. Morgan
Mol Cancer Ther February 1 2021 (20) (2) 263-273; DOI: 10.1158/1535-7163.MCT-20-0365
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer
Leslie A. Parsels, Carl G. Engelke, Joshua Parsels, Sheryl A. Flanagan, Qiang Zhang, Daria Tanska, Daniel R. Wahl, Christine E. Canman, Theodore S. Lawrence and Meredith A. Morgan
Mol Cancer Ther February 1 2021 (20) (2) 263-273; DOI: 10.1158/1535-7163.MCT-20-0365
Jump to section
Advertisement